Experts debate over fibromyalgia, treatments

01/13/2008 | NYTimes.com

Patient advocates and some providers say the Pfizer drug Lyrica could help promote acceptance of fibromyalgia, a condition characterized by constant, widespread pain of unexplained origin. However, some health professionals don't consider the condition a medically recognizable illness and say that diagnosis could worsen the symptoms and that the drug could cause harmful side effects.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ